JPS5535049A - Amino acid transfusion for cancerous patient - Google Patents

Amino acid transfusion for cancerous patient

Info

Publication number
JPS5535049A
JPS5535049A JP10874978A JP10874978A JPS5535049A JP S5535049 A JPS5535049 A JP S5535049A JP 10874978 A JP10874978 A JP 10874978A JP 10874978 A JP10874978 A JP 10874978A JP S5535049 A JPS5535049 A JP S5535049A
Authority
JP
Japan
Prior art keywords
amino acid
transfusion
methionine
acid transfusion
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10874978A
Other languages
Japanese (ja)
Other versions
JPS6154007B2 (en
Inventor
Koji Koseki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP10874978A priority Critical patent/JPS5535049A/en
Priority to GB7929789A priority patent/GB2029220B/en
Priority to AU50368/79A priority patent/AU526207B2/en
Priority to CA334,841A priority patent/CA1134275A/en
Priority to IT05216/79A priority patent/IT1194844B/en
Priority to SE7907316A priority patent/SE448679B/en
Priority to FR7921975A priority patent/FR2434622A1/en
Priority to DE2935709A priority patent/DE2935709C2/en
Priority to CH799179A priority patent/CH642541A5/en
Priority to NLAANVRAGE7906620,A priority patent/NL190266C/en
Publication of JPS5535049A publication Critical patent/JPS5535049A/en
Publication of JPS6154007B2 publication Critical patent/JPS6154007B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

PURPOSE: To provide an amino acid transfusion for cancerous patient, containing essential amino acids other than methionine, and having cancer cell-decreasing or carcinostatic effect.
CONSTITUTION: An amino acid transfusion devoid of methionine. Especially a transfusion containing leucine, isoleucine, lysine, phenylalanine, threonine and tryptophane. The known amino acid transfusion is nutrient to the cancer cells as well as the normal cells, and is not effective to the increase in weight or the improvement of the condition of the patient. In contrast with the above, the transfusion free of methionine suppresses the proliferation of cancer cells selectively, and is effective to the increase in weight, etc.
COPYRIGHT: (C)1980,JPO&Japio
JP10874978A 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient Granted JPS5535049A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient
GB7929789A GB2029220B (en) 1978-09-04 1979-08-28 Amino acid solutions for patients with cancers
AU50368/79A AU526207B2 (en) 1978-09-04 1979-08-29 Amino acid solutions as food for patients with cancer
CA334,841A CA1134275A (en) 1978-09-04 1979-08-31 Amino acid solutions for patients with cancers
IT05216/79A IT1194844B (en) 1978-09-04 1979-09-03 AMINO ACID SOLUTION FOR PATIENTS WITH CARCINOMA
SE7907316A SE448679B (en) 1978-09-04 1979-09-03 INFUSION SOLUTION FOR CANCER PATIENTS CONTAINING ESSENTIAL AMINO ACIDS BUT IS FREE OF METIONIN
FR7921975A FR2434622A1 (en) 1978-09-04 1979-09-03 AMINO ACID SOLUTIONS FOR THE FEEDING OF CANCER PATIENTS
DE2935709A DE2935709C2 (en) 1978-09-04 1979-09-04 Amino acid solution used to treat people with cancer
CH799179A CH642541A5 (en) 1978-09-04 1979-09-04 ESSENTIAL SOLUTION CONTAINING AMINO ACIDS FOR ADMINISTRATION TO CANCER PATIENTS.
NLAANVRAGE7906620,A NL190266C (en) 1978-09-04 1979-09-04 AMINO ACID SOLUTION FOR CANCER PATIENTS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
JPS5535049A true JPS5535049A (en) 1980-03-11
JPS6154007B2 JPS6154007B2 (en) 1986-11-20

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10874978A Granted JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Country Status (10)

Country Link
JP (1) JPS5535049A (en)
AU (1) AU526207B2 (en)
CA (1) CA1134275A (en)
CH (1) CH642541A5 (en)
DE (1) DE2935709C2 (en)
FR (1) FR2434622A1 (en)
GB (1) GB2029220B (en)
IT (1) IT1194844B (en)
NL (1) NL190266C (en)
SE (1) SE448679B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813512A (en) * 1981-07-03 1983-01-26 シャルル・シャニ Drug containing reactants of c1-c6 carboxylic acid and basic amino acid
EP0560989A4 (en) * 1991-10-07 1994-02-02 Otsuka Pharmaceutical Factory, Inc.
JPH07501083A (en) * 1992-08-29 1995-02-02 ウエラ　アクチェンゲゼルシャフト Hair setting agents based on lignin or lignin derivatives and dihydroxypropyl lignin
JP2005518361A (en) * 2001-11-27 2005-06-23 ブルジンスキー，スタニスロー・アール A combination of amino acids and riboflavin useful to reduce the toxic effects of cytotoxic chemotherapy
JP2016117702A (en) * 2014-12-22 2016-06-30 武輝 山田 Method for destroying cancer cells

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003552A1 (en) * 1981-04-17 1982-10-28 Hospital Supply Corp American Improved solution for parenteral nutrition
DE3329253A1 (en) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Use of an amino acid mixture for the control of, in particular, lymphadenomas
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (en) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell MEDICINAL SOLUTION CONTAINING AMINOSAUR SOLUTIONS FOR THE TREATMENT OF CANCER DISEASES AND METHOD FOR THE PRODUCTION THEREOF
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (en) * 1985-12-19 1988-11-10 Centre Nat Rech Scient METHIONINE-DEFECTED NUTRITIONAL COMPOSITIONS FOR INHIBITING THE DEVELOPMENT AND DISSEMINATION OF MALIGNANT TUMORS IN MAMMALS
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
ES2184756T3 (en) * 1992-11-19 2003-04-16 Anticancer Inc USE OF METIONINASE AS AN ANTITUMORAL AGENT IN ANTIMETIONINE CHEMOTHERAPY.
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
CA2260886A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
ATE323479T1 (en) * 2000-06-16 2006-05-15 Matthias Dr Med Rath COMPOSITION FOR THE PREVENTION OF SMOOTH MUSCLE DISEASES CONTAINING ASCORBATE, ARGININE AND MAGNESIUM
DK1195159T3 (en) * 2000-10-09 2006-10-02 Matthias Dr Med Rath Therapeutic combination of ascorbate with lysine and arginine for the prevention or treatment of cancer
US6974833B2 (en) 2001-01-16 2005-12-13 Matthias Rath Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (en) * 2001-10-05 2003-04-17 Tetsuro Asao Immune system activators
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
EP1734819A1 (en) * 2004-03-19 2006-12-27 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
CN101232822B (en) * 2005-07-29 2012-11-14 蒂马基金会 Composition for reducing the risc of ethanol metabolism and alcohol induced neuropathy
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
PL2156188T3 (en) 2007-03-28 2021-11-15 University Of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
WO2009132320A2 (en) 2008-04-24 2009-10-29 University Of Southern California, Usc Stevens Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
KR101919747B1 (en) * 2011-02-17 2018-11-20 각꼬호우진 구루메 다이가쿠 Potentiator of antitumor activity of chemotherapeutic agent
JOP20190146A1 (en) 2016-12-19 2019-06-18 Axcella Health Inc Amino acid compositions and methods for the treatment of liver diseases
CN111295187A (en) 2017-08-14 2020-06-16 胺细拉健康公司 Amino acid composition for treating liver diseases
AR115585A1 (en) 2018-06-20 2021-02-03 Axcella Health Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF FAT INFILTRATION IN MUSCLE
IT202000000454A1 (en) * 2020-01-13 2021-07-13 Professional Dietetics Spa COMPOSITIONS INCLUDING AMINO ACIDS FOR THE PREVENTION AND TREATMENT OF CANCER

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (en) * 1968-05-09 1972-04-10 Astra Ab Process for the preparation of an infusion solution of essential amino acids for intravenous delivery in uremic conditions
SU423304A3 (en) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (en) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Agents for the treatment and prevention of liver diseases and muscular insufficiency
DE2530246A1 (en) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE
DE2531204A1 (en) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813512A (en) * 1981-07-03 1983-01-26 シャルル・シャニ Drug containing reactants of c1-c6 carboxylic acid and basic amino acid
EP0560989A4 (en) * 1991-10-07 1994-02-02 Otsuka Pharmaceutical Factory, Inc.
JPH07501083A (en) * 1992-08-29 1995-02-02 ウエラ　アクチェンゲゼルシャフト Hair setting agents based on lignin or lignin derivatives and dihydroxypropyl lignin
JP2005518361A (en) * 2001-11-27 2005-06-23 ブルジンスキー，スタニスロー・アール A combination of amino acids and riboflavin useful to reduce the toxic effects of cytotoxic chemotherapy
JP2016117702A (en) * 2014-12-22 2016-06-30 武輝 山田 Method for destroying cancer cells

Also Published As

Publication number Publication date
DE2935709C2 (en) 1986-02-06
NL7906620A (en) 1980-03-06
NL190266C (en) 1994-01-03
AU526207B2 (en) 1982-12-23
DE2935709A1 (en) 1980-03-13
NL190266B (en) 1993-08-02
CA1134275A (en) 1982-10-26
CH642541A5 (en) 1984-04-30
IT1194844B (en) 1988-09-28
FR2434622B1 (en) 1983-04-15
SE7907316L (en) 1980-03-05
GB2029220B (en) 1983-03-30
JPS6154007B2 (en) 1986-11-20
IT7905216A0 (en) 1979-09-03
FR2434622A1 (en) 1980-03-28
AU5036879A (en) 1980-03-13
GB2029220A (en) 1980-03-19
SE448679B (en) 1987-03-16

Similar Documents

Publication Publication Date Title
JPS5535049A (en) Amino acid transfusion for cancerous patient
NZ218734A (en) Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid)
JPS5735516A (en) Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
ES478967A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
JPS57136596A (en) Carcinostatic substance tf-240, its preparation, and carcinostatic agent containing the same
JPS5791913A (en) Pharmaceutical preparation of drug
JPS5391189A (en) Preparation of d-n-carbamoyl-alpha-amino acids
JPS5648857A (en) Low-protein feed
ES8205190A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
JPS5386091A (en) Preparation of l-lysine by fermentation
JPS5668374A (en) Food composition for hepatic insufficiency
IL68085A (en) 3-acyl derivatives of 2-or 4-thiazolidine carboxylic acid,their preparation and their use as plant-growth regulants
JPS532433A (en) Hydrolysis of #-phenylenediamine
JPS54157838A (en) Preventive for cerebral apoplexy
JPS5411233A (en) Anitidote
JPS542398A (en) Preparation of d-alpha-amino acid
JPS5328119A (en) Preparation of pantetheine
JPS5275580A (en) Process for the preparation of feed
JPS5257129A (en) Process for hydroquinone
GB1499778A (en) Treatment of swine dysentery
JPS5312491A (en) Preparation of l-alginine by fermentation
JPS5337690A (en) Novel pyridinophans their preparation and racemization catalysis containing the same for amino acids
JPS646084A (en) Latent heat-type heat storage material
JPS532432A (en) Preparation of resorcin
JPS5283421A (en) Preparation of phenoxypropylamine derivatives